Namouni Fouad 4
4 · Blueprint Medicines Corp · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Namouni Fouad
PRESIDENT, R & D
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+26,400→ 26,400 totalExercise: $96.57Exp: 2035-02-28→ Common Stock (26,400 underlying) - Award
Common Stock
2025-03-01+13,200→ 82,270 total
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of grant of 13,200 restricted stock units under the Issuer's 2024 Stock Incentive Plan.
- [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2025 and as to an additional 1/48th of the shares underlying the option each month thereafter.